Martin Zalesak

Martin Zalesak is an author at Novartis (United States) specializing in multiple sclerosis pharmacotherapy, multiple sclerosis therapy, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2013–2022

5

Publications

5